139 related articles for article (PubMed ID: 2880518)
1. Lithium and extrapyramidal side effects of neuroleptics.
Weiden P
Am J Psychiatry; 1987 Feb; 144(2):264-5. PubMed ID: 2880518
[No Abstract] [Full Text] [Related]
2. Extrapyramidal symptoms with addition of lithium to neuroleptics.
Murphy DJ; Gannon MA; Hartman ML
J Nerv Ment Dis; 1989 Nov; 177(11):708. PubMed ID: 2572677
[No Abstract] [Full Text] [Related]
3. Increased extrapyramidal symptoms with addition of lithium to neuroleptics.
Addonizio G; Roth SD; Stokes PE; Stoll PM
J Nerv Ment Dis; 1988 Nov; 176(11):682-5. PubMed ID: 2903220
[TBL] [Abstract][Full Text] [Related]
4. Delirium and extrapyramidal symptoms due to a lithium-olanzapine combination therapy: a case report.
Tuglu C; Erdogan E; Abay E
J Korean Med Sci; 2005 Aug; 20(4):691-4. PubMed ID: 16100469
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of propranolol in a patient with tardive dyskinesia and extrapyramidal syndrome.
Chaudhry R; Radonjic D; Waters B
Am J Psychiatry; 1982 May; 139(5):674-6. PubMed ID: 6122382
[No Abstract] [Full Text] [Related]
6. Serum neuroleptic levels and extrapyramidal side effects in patients treated with amoxapine.
Gaffney GR; Tune LE
J Clin Psychiatry; 1985 Oct; 46(10):428-9. PubMed ID: 2864332
[TBL] [Abstract][Full Text] [Related]
7. Lithium-neuroleptic neurotoxicity in the elderly bipolar patient.
Miller F; Menninger J; Whitcup SM
J Clin Psychopharmacol; 1986 Jun; 6(3):176-8. PubMed ID: 2872237
[TBL] [Abstract][Full Text] [Related]
8. Extrapyramidal side effects with lithium treatment.
Kane J; Rifkin A; Quitkin F; Klein DF
Am J Psychiatry; 1978 Jul; 135(7):851-3. PubMed ID: 665801
[TBL] [Abstract][Full Text] [Related]
9. Nonneuroleptic etiologies of extrapyramidal symptoms.
Blair DT; Dauner A
Clin Nurse Spec; 1993 Jul; 7(4):225-31. PubMed ID: 8102320
[TBL] [Abstract][Full Text] [Related]
10. Therapy of extrapyramidal side effects, with particular reference to persistent dyskinesia and lithium tremor.
Pöldinger W
Int Pharmacopsychiatry; 1978; 13(4):230-3. PubMed ID: 32149
[TBL] [Abstract][Full Text] [Related]
11. [Neuroleptics and extrapyramidal effects from the biochemical viewpoint. Discussion by the Workshop on Neuroleptics and the Extrapyramidal System].
Seyfried C
Arzneimittelforschung; 1978; 28(9):1537-8. PubMed ID: 38815
[No Abstract] [Full Text] [Related]
12. Lithium potentiation of neuroleptic-related extrapyramidal side effects.
Sachdev PS
Am J Psychiatry; 1986 Jul; 143(7):942. PubMed ID: 3087223
[No Abstract] [Full Text] [Related]
13. Decreased extrapyramidal side effects and polypsichopharmacy in family practice outpatients.
Holt RJ
Bol Asoc Med P R; 1983 Aug; 75(8):351-2. PubMed ID: 6139115
[No Abstract] [Full Text] [Related]
14. [Extrapyramidal effects of antipsychotic drugs].
Kulisevsky J; Otermin P
Neurologia; 2003 Jun; 18(5):262-8. PubMed ID: 12768512
[TBL] [Abstract][Full Text] [Related]
15. [Neuroleptics and the extrapyramidal system].
Haase HJ
Arzneimittelforschung; 1978; 28(9):1536-7. PubMed ID: 38814
[No Abstract] [Full Text] [Related]
16. Extrapyramidal side-effect due to drug combination of risperidone and donepezil.
Liu HC; Lin SK; Sung SM
Psychiatry Clin Neurosci; 2002 Aug; 56(4):479. PubMed ID: 12109969
[No Abstract] [Full Text] [Related]
17. Extrapyramidal side effects of antipsychotic medications.
Harris E
Am J Nurs; 1981 Jul; 81(7):1324-8. PubMed ID: 6113762
[No Abstract] [Full Text] [Related]
18. Fluoxetine and extrapyramidal side effects.
Coulter DM; Pillans PI
Am J Psychiatry; 1995 Jan; 152(1):122-5. PubMed ID: 7802102
[TBL] [Abstract][Full Text] [Related]
19. [Persistent neurological syndrome after treatment with lithium salts. Toxicity of the lithium-neuroleptic combination?].
Habib M; Khalil R; le Pensec-Bertrand D; Ali-Cherif A; Bongrand MC; Crevat A
Rev Neurol (Paris); 1986; 142(1):61-4. PubMed ID: 2871617
[TBL] [Abstract][Full Text] [Related]
20. Differential reversal by scopolamine of effects of neuroleptics in rats. Relevance for evaluation of therapeutic and extrapyramidal side-effect potential.
Arnt J; Christensen AV; Hyttel J
Neuropharmacology; 1981 Dec; 20(12B):1331-4. PubMed ID: 6119645
[No Abstract] [Full Text] [Related]
[Next] [New Search]
